Cargando…
Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide
Pathogen-based cancer vaccine is a promising immunotherapeutic weapon to stimulate cancer immunosuppressive state. Toxoplasma gondii is a potent immunostimulant, and low-dose infection was linked to cancer resistance. Our goal was to evaluate the therapeutic antineoplastic activity of autoclaved Tox...
Autores principales: | Ismail, Cherine A., Eissa, Maha M., Gaafar, Maha R., Younis, Layla K., El Skhawy, Nahla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073061/ https://www.ncbi.nlm.nih.gov/pubmed/37014499 http://dx.doi.org/10.1007/s12032-023-01994-y |
Ejemplares similares
-
Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting
por: Eissa, Maha M., et al.
Publicado: (2023) -
Recent Advances in Toxoplasma gondii Immunotherapeutics
por: Lim, Sherene Swee-Yin, et al.
Publicado: (2014) -
Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains
por: Silva, L.A., et al.
Publicado: (2012) -
Effects of Green cardamom (Elettaria cardamomum Maton) and its combination with cyclophosphamide on Ehrlich solid tumors
por: Almeer, Rafa S., et al.
Publicado: (2021) -
Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice
por: Aldubayan, Maha Abdulrahman
Publicado: (2020)